Home Tags IPOs
Jack Dorsey’s $35 billion fintech firm Square has stopped in-person job interviews as a coronavirus precaution
The mobile payments firm is also "strongly encouraging" staff to start working from home if they can.
The firm has been working toward a stock market debut and was reportedly looking to start the process around March or April.
Goldman Sachs CEO says no IPOs for companies without at least one ‘diverse’ board member starting in July
In the last four years, US IPOs with a woman on the board have performed "significantly better" than those without, Goldman Sachs CEO said.
Deloitte’s IPO guru told us how a tumultuous market and the upcoming election could delay firms looking to go public
Companies looking to go public see June as the last opportunity to do so before presidential campaigns affect market volatility, Previn Waas said.
The proportion of cash-burning companies going public has reached 70%, according to Bank of America data.
It's been a tough landscape lately. The Renaissance Capital IPO ETF, which tracks the broader IPO market, has fallen almost 8% over the last month.
Goldman Sachs analyzed 4,481 IPOs over 25 years and concluded that these 5 attributes can make or break a newly public company
Money-losing startups like Uber, Lyft, and Pinterest have all gone public in 2019 after years of raking in venture capital funding.
Saudi Aramco is reportedly considering a 2-stage IPO — but geopolitical chaos could shut out London and Hong Kong from the world’s largest...
Hong Kong and London have been lobbying over the last several years to host the world's largest IPO.
WeWork is just one of the businesses owned by the $47 billion company that just filed for its IPO — check out the full list
Originally called WeWork, the We Company rebranded at the start of 2019 in order to make room for spin-off businesses WeLive, WeGrow, and Rise by We.
Dispensed: A big week for digital health IPOs, what happens when a $2.1 million drug can’t get to the kids who need it, and what a top health-te...
Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.